{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:40:23Z","timestamp":1780731623043,"version":"3.54.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.trstmh.2010.07.007","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T09:05:21Z","timestamp":1285664721000},"page":"706-712","source":"Crossref","is-referenced-by-count":21,"title":["Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection"],"prefix":"10.1093","volume":"104","author":[{"given":"Workagegnehu","family":"Hailu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teklu","family":"Weldegebreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewdu","family":"Hurissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailemariam","family":"Tafes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Omollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisay","family":"Yifru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manica","family":"Balasegaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.trstmh.2010.07.007_bib0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00001432-200212000-00007","article-title":"Advances in the treatment of leishmaniasis","volume":"15","author":"Sundar","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728210903153862","article-title":"Developments in the treatment of visceral leishmaniasis","volume":"14","author":"Den Boer","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","volume":"97","author":"Rijal","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/520665","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions","volume":"45","author":"Sundar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"In vitro susceptibility of field isolates of Leishmania donovani to miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity","volume":"53","author":"Kumar","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome","volume":"95","author":"Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-3156.2000.00555.x","article-title":"A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan","volume":"5","author":"Veeken","year":"2000","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0040","first-page":"388","article-title":"Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya","volume":"79","author":"Moore","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/136485908X252142","article-title":"Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda","volume":"102","author":"Mueller","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0050","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-3156.2009.02305.x","article-title":"Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda","volume":"14","author":"Mueller","year":"2009","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0001-706X(94)90096-5","article-title":"Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation","volume":"57","author":"Berhe","year":"1994","journal-title":"Acta Trop"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0060","unstructured":"WHO. Control of the leishmaniasis. Geneva: World Health Organization; 1990. Technical Report Series No. 793, p. 153\u20135."},{"key":"10.1016\/j.trstmh.2010.07.007_bib0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0001-706X(01)00156-5","article-title":"Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study","volume":"80","author":"Berhe","year":"2001","journal-title":"Acta Trop"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jac\/dkg356","article-title":"Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study","volume":"52","author":"Laguna","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00034989859258","article-title":"Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases","volume":"92","author":"Thakur","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0085","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4269\/ajtmh.1999.61.766","article-title":"High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients","volume":"61","author":"Delgado","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.medmal.2004.07.032","article-title":"Glucantime injection: benefit versus toxicity","volume":"35","author":"Masmoudi","year":"2005","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0095","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1258\/td.2008.080369","article-title":"Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern regions of Brazil","volume":"39","author":"Oliveira","year":"2009","journal-title":"Trop Doct"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jac\/dkg340","article-title":"Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995\u20132001)","volume":"52","author":"Pagliano","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0105","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4314\/eamj.v78i11.8952","article-title":"Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis","volume":"78","author":"Berhe","year":"2001","journal-title":"East Afr Med J"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0110","first-page":"CR290","article-title":"Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children","volume":"15","author":"Shahian","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4314\/ejhd.v21i1.10032","article-title":"Visceral leishmaniasis and HIV co-infection in patients admitted to Gondar University Hospital, northwest Ethiopia","volume":"21","author":"Mengistu","year":"2007","journal-title":"Ethiop J Health Dev"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0120","first-page":"199","article-title":"Kala-azar among labour migrants in Metema-Humera region of Ethiopia","volume":"30","author":"Mengesha","year":"1978","journal-title":"Trop Geogr Med"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.1979.28.15","article-title":"Clinical and laboratory features and treatment of visceral leishmaniasis in hospitalized patients in north-west Ethiopia","volume":"28","author":"Maru","year":"1979","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/510398","article-title":"HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis","volume":"195","author":"Barat","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0135","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"Ter Horst","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s100960100457","article-title":"Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy","volume":"20","author":"Casado","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijantimicag.2005.04.003","article-title":"Antileishmanial activity of HIV protease inhibitors","volume":"26","author":"Savoia","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.trstmh.2010.07.007_bib0150","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1086\/592280","article-title":"Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors","volume":"198","author":"Trudel","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/104\/11\/706\/17469435\/104-11-706.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T03:31:39Z","timestamp":1559705499000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article-lookup\/doi\/10.1016\/j.trstmh.2010.07.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0035920310001677"],"URL":"https:\/\/doi.org\/10.1016\/j.trstmh.2010.07.007","relation":{},"ISSN":["0035-9203"],"issn-type":[{"value":"0035-9203","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}